|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.020 EUR | +1.52% |
|
+1.52% | +8.65% |
| 05-05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 191M 218M 175M 164M 310M 20.8B 315M 2.11B 819M 10.22B 820M 802M 35.23B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 191M 218M 175M 164M 310M 20.8B 315M 2.11B 819M 10.22B 820M 802M 35.23B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.24x |
| Free-Float |
12.27% | Yield 2026 * |
1% | Yield 2027 * | 1% |
| 1 day | +1.52% | ||
| 1 week | +1.52% | ||
| Current month | +1.52% | ||
| 1 month | -3.37% | ||
| 3 months | +17.54% | ||
| 6 months | +11.67% | ||
| Current year | +8.65% |
| 1 week | 3.9 |  | 4.02 |
| 1 month | 3.88 | | 4.2 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.26 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 31/12/2002 |
Michael Bock
BRD | Director/Board Member | 63 | 24/05/2005 |
| Director/Board Member | 63 | 19/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | +1.52% | +34.90% | +30.52% | 218M | |
| -0.24% | -4.57% | +18.98% | +38.61% | 17.69B | |
| +2.27% | +3.51% | +17.56% | +75.47% | 13.43B | |
| +1.06% | +6.88% | -30.66% | -54.98% | 11.71B | |
| +5.00% | +5.06% | -10.57% | +58.54% | 10.56B | |
| +2.06% | +3.17% | +12.01% | +79.17% | 9.75B | |
| +2.03% | +6.35% | -0.99% | -27.57% | 9.63B | |
| -0.04% | +2.07% | +22.74% | +210.63% | 7.73B | |
| +1.21% | +2.46% | +14.17% | -22.19% | 7.04B | |
| +0.45% | -0.89% | -16.79% | - | 6.75B | |
| Average | +1.53% | +1.54% | +6.14% | +43.13% | 9.45B | |
| Weighted average by Cap. | +1.51% | +1.14% | +4.01% | +41.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 901M 724M 675M 1.28B 85.77B 1.3B 8.69B 3.38B 42.16B 3.38B 3.31B 145B | 803M 919M 738M 688M 1.31B 87.48B 1.32B 8.86B 3.45B 43B 3.45B 3.37B 148B |
| Net income | 36.66M 41.94M 33.69M 31.41M 59.57M 3.99B 60.47M 404M 157M 1.96B 157M 154M 6.76B | 38.2M 43.69M 35.1M 32.72M 62.06M 4.16B 63M 421M 164M 2.04B 164M 160M 7.05B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | €4.020 | +1.52% | 4,215 |
| 02/07/26 | €3.960 | -0.50% | 893 |
| 01/07/26 | €3.980 | +0.51% | 501 |
| 30/06/26 | €3.960 | 0.00% | 3,368 |
| 29/06/26 | €3.960 | 0.00% | 876 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.020EUR
Average target price
7.300EUR
Spread / Average Target
+81.59%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
